Jerome J Terrence Jose
Department of Orthopedics, Hand and Reconstructive Microsurgery, Olympia Hospital & Research Centre, Tiruchirappalli, India.
JBJS Essent Surg Tech. 2025 Mar 20;15(1). doi: 10.2106/JBJS.ST.24.00018. eCollection 2025 Jan-Mar.
Spasticity in the upper limb following stroke or traumatic brain injury substantially impairs function and quality of life by affecting the flexor and adductor muscles. Spasticity commonly presents with deformities such as shoulder adduction and internal rotation, elbow flexion, forearm pronation, wrist flexion, finger flexion, and thumb adduction-commonly referred to as "thumb-in-palm" deformity. As the spasticity is incurable, surgical interventions aim to improve function and aesthetics, and facilitate daily care. Procedures such as tendon transfers and fractional lengthening can be limited by persistent spasticity, which may mask the underlying pathology, leading to misjudgments during surgery. Hyperselective neurectomy (HSN) is a surgical technique targeting specific motor nerve branches to reduce spasticity while preserving voluntary function. Traditionally performed with the patient under general anesthesia, HSN presents challenges, as the relaxed muscles may obscure the degree of spasticity. Performing HSN with the patient receiving local anesthesia and without the use of a tourniquet offers real-time evaluation of muscle function, enabling precise surgical adjustments and minimizing unnecessary nerve resection. Additionally, HSN provides flexibility to incorporate tendon transfers or fractional lengthening intraoperatively, as appropriate.
With the patient under local anesthesia, a longitudinal incision exposes the median and ulnar nerves from the elbow to the forearm. The median nerve branches innervate the pronator teres, flexor carpi radialis (FCR), flexor digitorum profundus (FDP), and flexor digitorum superficialis (FDS), while the anterior interosseous nerve innervates the flexor pollicis longus. The ulnar nerve innervates the flexor carpi ulnaris (FCU) and FDP, with branches arising near the medial epicondyle. Selective neurectomy targets two-thirds to three-quarters of the nerve fascicles responsible for spastic movements, preserving sufficient fascicles for voluntary control. For example, patients with flexion-pronation deformities and weak wrist dorsiflexion may benefit from neurectomy of the pronator teres and wrist flexor branches. No cauterization is applied proximal to the nerve stumps in order to avoid further complications. The surgeon can also consider tendon transfers, such as transferring the extensor carpi ulnaris (ECU) to the extensor carpi radialis brevis (ECRB) in order to enhance wrist dorsiflexion. After partial neurectomy of the flexor pollicis longus, the patient can demonstrate thumb extension intraoperatively. The use of local rather than general anesthesia allows continuous feedback from the awake patient, ensuring accurate spasticity reduction and helping to assess the need for further interventions. Intraoperative neurostimulation aids in accurately identifying motor branches and avoiding sensory nerves. This method enables fine-tuning of the neurectomy to achieve optimal outcomes without excessive nerve resection that could compromise muscle strength.
Alternative treatments for spasticity include physical therapy, oral medications, botulinum toxin injections, and intrathecal baclofen pumps. However, these options may have limited efficacy, have side effects, or require more studies.
Selective neurectomy offers several advantages over other treatments. (1) A targeted approach. Unlike systemic medications or generalized nerve blocks, HSN specifically addresses the nerves responsible for spasticity, sparing other muscles. (2) A long-lasting effect. Whereas medications and botulinum toxin provide temporary relief, HSN offers longer-lasting spasticity reduction. (3) Functional improvement. The procedure enhances specific movements, such as wrist dorsiflexion and thumb extension. It also allows for intraoperative tendon transfer as needed in order to address persistent deformities. HSN is not typically a first-line treatment but is considered when nonoperative treatment has failed. HSN is particularly suitable in patients with focal spasticity who retain some voluntary control and who possess sufficient passive range of motion. The procedure may also be combined with single-event multilevel surgery for more comprehensive upper-limb reconstruction.
Patients undergoing HSN can expect substantial reduction in spasticity and improved functional range of motion. In a prospective trial including 18 HSN procedures involving the pronator teres, Leclercq et al. reported significant improvements in forearm resting position and spasticity parameters at the latest follow-up. Similar procedures on wrist flexors, including the FCR, FCU, and pronator teres, have shown moderate wrist extension improvement without compromising flexor strength. Hysong et al. reported that House scores improved from 2.2 to 3.4 on average and that surgical goals were achieved in 93% of patients, with no postoperative complications or permanent strength loss reported. Although outcomes may vary according to individual patient factors, HSN provides long-lasting improvements in function and spasticity control, contributing to higher patient satisfaction. Additional tendon transfers may further enhance outcomes.
Ideal candidates for HSN exhibit focal spasticity that is unresponsive to nonoperative treatments, with functional wrist and finger flexors and weak extensors.Local anesthesia without a tourniquet allows for real-time nerve stimulation and precise identification of target branches, enabling the patient to actively participate in intraoperative assessments before and after the neurectomy.A curvilinear incision ensures adequate exposure and identification of individual nerve branches.Target only the motor fascicles causing spasticity while preserving sensory branches in order to maintain function.Tendon transfers, such as ECU to ECRB, enhance wrist dorsiflexion.Postoperative rehabilitation is crucial to prevent complications and maximize functional gains.Anatomical variations can complicate nerve identification.Excessive fascicle resection may result in unintended muscle weakness.Inadequate resection may not sufficiently reduce spasticity.Potential complications include infection, hematoma, nerve injury, and chronic pain.
PT = pronator teresHSN = hyperselective neurectomyECU = extensor carpi ulnarisECRB = extensor carpi radialis brevisFCR = flexor carpi radialisFDP = flexor digitorum profundusFDS = flexor digitorum superficialisFPL = flexor pollicis longusEPL = extensor pollicis longusEDM = extensor digiti minimiECRL = extensor carpi radialis longusWALANT = wide awake local anesthesia no tourniquetFCU = flexor carpi ulnaris.
中风或创伤性脑损伤后上肢的痉挛会通过影响屈肌和内收肌严重损害功能和生活质量。痉挛通常会导致诸如肩部内收和内旋、肘部屈曲、前臂旋前、手腕屈曲、手指屈曲以及拇指内收(通常称为“拇指握在掌心”畸形)等畸形。由于痉挛无法治愈,手术干预旨在改善功能和美观,并便于日常护理。肌腱转移和部分延长等手术可能会受到持续性痉挛的限制,这可能掩盖潜在病变,导致手术过程中出现误判。超选择性神经切除术(HSN)是一种针对特定运动神经分支的手术技术,可在保留自主功能的同时减轻痉挛。传统上,HSN是在全身麻醉下对患者进行的,这带来了挑战,因为放松的肌肉可能会掩盖痉挛程度。在患者接受局部麻醉且不使用止血带的情况下进行HSN可实时评估肌肉功能,实现精确的手术调整,并最大限度地减少不必要的神经切除。此外,HSN还可根据需要在术中灵活地进行肌腱转移或部分延长。
在患者处于局部麻醉状态下,做一个纵向切口,暴露从肘部到前臂的正中神经和尺神经。正中神经分支支配旋前圆肌、桡侧腕屈肌(FCR)、指深屈肌(FDP)和指浅屈肌(FDS),而骨间前神经支配拇长屈肌。尺神经支配尺侧腕屈肌(FCU)和FDP,其分支在肱骨内上髁附近发出。选择性神经切除术针对负责痉挛运动的三分之二至四分之三的神经束,保留足够的神经束以进行自主控制。例如,患有屈曲 - 旋前畸形且腕背伸无力的患者可能受益于旋前圆肌和腕屈肌分支的神经切除术。在神经残端近端不进行烧灼,以避免进一步的并发症。外科医生还可考虑肌腱转移,例如将尺侧腕伸肌(ECU)转移至桡侧腕短伸肌(ECRB)以增强腕背伸。在拇长屈肌部分神经切除后,患者可在术中展示拇指伸展。使用局部麻醉而非全身麻醉可从清醒的患者获得持续反馈,确保准确减轻痉挛,并有助于评估是否需要进一步干预。术中神经刺激有助于准确识别运动分支并避免感觉神经。这种方法能够对神经切除术进行微调以实现最佳效果,同时避免过度切除神经而损害肌肉力量。
痉挛的替代治疗方法包括物理治疗、口服药物、肉毒杆菌毒素注射和鞘内巴氯芬泵。然而,这些选择可能疗效有限、有副作用或需要更多研究。
与其他治疗方法相比,选择性神经切除术具有几个优点。(1)靶向性方法。与全身药物或全身性神经阻滞不同,HSN专门针对负责痉挛的神经,而不影响其他肌肉。(2)长期效果。药物和肉毒杆菌毒素只能提供暂时缓解,而HSN能更持久地减轻痉挛。(3)功能改善。该手术可增强特定动作,如腕背伸和拇指伸展。它还允许根据需要在术中进行肌腱转移以解决持续性畸形。HSN通常不是一线治疗方法,但在非手术治疗失败时会被考虑。HSN特别适用于患有局灶性痉挛且仍保留一些自主控制能力以及具有足够被动活动范围的患者。该手术也可与单事件多级手术相结合,以进行更全面的上肢重建。
接受HSN的患者预计痉挛会大幅减轻,功能活动范围得到改善。在一项包括18例涉及旋前圆肌的HSN手术的前瞻性试验中,勒克莱克等人报告在最新随访时前臂静止位置和痉挛参数有显著改善。对腕屈肌(包括FCR、FCU和旋前圆肌)进行的类似手术显示腕伸展有适度改善,且不影响屈肌力量。希松等人报告豪斯评分平均从2.2提高到3.4,93%的患者实现了手术目标,且未报告术后并发症或永久性力量丧失。尽管结果可能因个体患者因素而异,但HSN能在功能和痉挛控制方面带来长期改善,提高患者满意度。额外的肌腱转移可能会进一步改善结果。
HSN的理想候选人表现为局灶性痉挛,对非手术治疗无反应,腕和手指屈肌功能正常但伸肌较弱。不使用止血带的局部麻醉可实现实时神经刺激并精确识别目标分支,使患者能够在神经切除术前和术后积极参与术中评估。曲线形切口可确保充分暴露并识别各个神经分支。仅针对引起痉挛的运动神经束,同时保留感觉神经分支以维持功能。肌腱转移,如将ECU转移至ECRB,可增强腕背伸。术后康复对于预防并发症和最大化功能恢复至关重要。解剖变异可能使神经识别复杂化。过度切除神经束可能导致意外的肌肉无力。切除不足可能无法充分减轻痉挛。潜在并发症包括感染、血肿、神经损伤和慢性疼痛。
PT = 旋前圆肌;HSN = 超选择性神经切除术;ECU = 尺侧腕伸肌;ECRB = 桡侧腕短伸肌;FCR = 桡侧腕屈肌;FDP = 指深屈肌;FDS = 指浅屈肌;FPL = 拇长屈肌;EPL = 拇长伸肌;EDM = 小指伸肌;ECRL = 桡侧腕长伸肌;WALANT = 清醒局部麻醉无止血带;FCU = 尺侧腕屈肌。